MAPK8 and prostate carcinoma: Treatment with bioactive ceramide also induces apoptosis in AR expressing LNCaP prostate cancer cells by causing nuclear fragmentation and activation of c-Jun N-terminal kinase (JNK), independent of PKC pathways [79].